Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(2)

Detailed Status

Completed1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed133%
withdrawn133%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
completed

Modeling Bronchial Epithelium Modifications Associated With COPD Using iPS

NCT03181204
terminatednot_applicable

Ciliation and Mucus Rheology Parameters Determined Via Air-liquid-interface Cell Cultures in Non-smoking, Smoking, COPD and Asthmatic Patients

NCT03187860
withdrawnnot_applicable

Expressions of TRPV1 in Airway of Asthmatics

NCT02952066

Clinical Trials (3)

Showing 3 of 3 trials
NCT03181204

Modeling Bronchial Epithelium Modifications Associated With COPD Using iPS

Completed
NCT03187860Not Applicable

Ciliation and Mucus Rheology Parameters Determined Via Air-liquid-interface Cell Cultures in Non-smoking, Smoking, COPD and Asthmatic Patients

Terminated
NCT02952066Not Applicable

Expressions of TRPV1 in Airway of Asthmatics

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3